Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy
Background: Prostate cancer stands as the second most common malignancy among men, notorious for its intricate heterogeneity, especially evident in metastatic disease. This complexity presents substantial challenges in treatment efficacy and patient prognosis. Objective: This study endeavors to eluc...
Saved in:
Main Authors: | Chen Ding, Jiange Wang, Jie Wang, Jiqiang Niu, Zhikai Xiahou, Zhou Sun, Zhenzhen Zhao, Dongyang Zeng |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-02-01
|
Series: | Translational Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523324003814 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanomaterials in cancer immunotherapy: targeting cancer-associated fibroblasts
by: Zhongsong Zhang, et al.
Published: (2025-01-01) -
Drug Delivery System Targeting Cancer-Associated Fibroblast for Improving Immunotherapy
by: Zhang Z, et al.
Published: (2025-01-01) -
Cancer-associated fibroblasts in carcinogenesis
by: Shufen Zhou, et al.
Published: (2025-01-01) -
Deciphering the heterogeneity and plasticity of the tumor microenvironment in liver cancer provides insights for prognosis
by: Yihao Sun, et al.
Published: (2025-01-01) -
Potential clinical application of the cancer antigen CA‑62 for differential diagnosis of prostate cancer and benign prostatic hyperplasia at the elevated prostate‑specific antigen
by: Zh. R. Cherkasova, et al.
Published: (2023-03-01)